Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
ISO 11663-15: Quality of Dialysis Fluid for Haemodialysis and Related Therapies – Technical Compliance Guide
Comprehensive overview of the international standard for dialysis fluid purity, including chemical contaminant limits, microbial requirements, monitoring protocols, and implementation best practices.
ISO 11663-15 (adopted in Canada as CAN/CSA‑ISO 11663‑15) specifies the minimum quality requirements for dialysis fluid used in haemodialysis and related therapies. This standard serves as a critical reference for healthcare facilities, water treatment system designers, and regulatory bodies to ensure patient safety and treatment efficacy. By establishing limits for chemical contaminants and microbiological impurities, the standard directly influences the design, operation, and monitoring of water purification and fluid delivery systems in dialysis units worldwide.
Scope and Applicability
ISO 11663-15 applies to dialysis fluid prepared from treated water and concentrates for haemodialysis, haemodiafiltration, haemofiltration, and related extracorporeal therapies. It covers fluid that comes into direct contact with the patient’s blood via the dialyzer membrane. The standard does not address the quality of the water used solely for reprocessing dialyzers or for cleaning equipment, although it may be referenced in conjunction with other standards such as ISO 23500 (guidance for dialysis fluids and concentrates) and ISO 13958 (concentrates for haemodialysis).
Healthcare providers, manufacturers of dialysis fluid preparation systems, and water treatment vendors must adhere to the requirements defined in this standard. Regulatory bodies in many countries have adopted ISO 11663-15 as a benchmark for licensing and accreditation of dialysis facilities.
Tip: When implementing ISO 11663-15, consider the entire fluid pathway—from feed water and purification system to the distribution loop and final dialysis station. A holistic approach prevents contamination at any point.
Technical Requirements
Chemical Contaminant Limits
The standard establishes maximum allowable concentrations for a wide range of chemical substances that may be present in the dialysis fluid. These limits are based on toxicological data and clinical evidence to protect patients from acute and chronic exposure. Table 1 summarises the key chemical contaminants and their maximum allowable concentrations (MAC) as specified in ISO 11663-15.
| Contaminant | Maximum Allowable Concentration (mg/L) |
|---|---|
| Aluminium (Al) | 0.01 |
| Arsenic (As) | 0.005 |
| Barium (Ba) | 0.10 |
| Cadmium (Cd) | 0.001 |
| Calcium (Ca) | 2.0 |
| Chlorine (free) | 0.5 |
| Chromium (Cr) | 0.014 |
| Copper (Cu) | 0.10 |
| Fluoride (F) | 0.20 |
| Lead (Pb) | 0.005 |
| Magnesium (Mg) | 4.0 |
| Mercury (Hg) | 0.0002 |
| Nitrate (as N) | 2.0 |
| Potassium (K) | 8.0 |
| Selenium (Se) | 0.09 |
| Silver (Ag) | 0.005 |
| Sodium (Na) | 70 |
| Sulfate (SO4) | 100 |
| Zinc (Zn) | 0.10 |
Table 1: Selected maximum allowable concentrations for chemical contaminants in dialysis water (based on ISO 11663-15).
Warning: Inadequate removal of chlorine and chloramines can lead to haemolytic anaemia in haemodialysis patients. Continuous monitoring of total chlorine (free and combined) is strongly recommended, especially when municipal water chlorination practices vary.
Microbiological Quality
Dialysis fluid must meet strict microbiological limits to prevent pyrogenic reactions and infection. ISO 11663-15 specifies the following culture-based limits:
- Bacterial count: ≤ 100 CFU/mL (at 35–37 °C, using a validated method such as R2A agar or tryptic soy agar).
- Endotoxin concentration: ≤ 0.25 EU/mL (Limulus amebocyte lysate test).
Facilities are required to perform regular microbiological sampling at representative points in the distribution loop, especially at the point of use (dialysis station). The standard recommends a minimum monitoring frequency: at least monthly for bacteria and endotoxin, with more frequent testing after system maintenance or changes in feed water quality.
Success: Facilities that consistently maintain bacterial counts below 10 CFU/mL and endotoxin below 0.03 EU/mL often report fewer pyrogenic reactions and lower morbidity among haemodialysis patients.
Monitoring and Testing
ISO 11663-15 requires periodic testing of both water and final dialysis fluid. Key elements include:
- Chemical analysis: At least annually for all regulated contaminants. Additional testing is needed when the source water quality changes (e.g., seasonal variations, new municipal treatment processes).
- Conductivity and pH: Continuous monitoring during treatment sessions to ensure proper mixing of concentrates and water.
- Microbiological sampling: Monthly endotoxin and heterotrophic plate counts. If alert limits are exceeded, corrective actions must be taken and repeated testing performed.
- Validation of treatment system: After installation, major repairs, or modification, the entire system must be validated to demonstrate compliance.
Danger: Failure to monitor chemical contaminants such as aluminium and copper can lead to severe neurological or bone diseases over time. Never skip the annual comprehensive chemical analysis.
Implementation Highlights
Implementing ISO 11663-15 requires a systems approach. Below are critical points to consider:
Water Purification System Design
The typical dialysis water treatment train includes backwashable sediment filtration, carbon adsorption (to remove chlorine and chloramines), water softening, reverse osmosis (RO), and final polishing (deionization or ultrafiltration). The system must be designed to continuously supply water meeting the standard’s limits, accounting for peak demand and possible feed water quality fluctuations.
Distribution and Storage
Dialysis water should be circulated in a closed loop with continuous flow to prevent stagnation and biofilm formation. Materials used for piping (e.g., cross‑linked polyethylene, stainless steel) must be chemically inert and capable of withstanding periodic disinfection (chemical or thermal).
Risk Management
Aligning with ISO 14971 (risk management for medical devices) is beneficial. Facilities should conduct a risk analysis focusing on chemical breakthrough, microbial contamination, and system failures. Alert and action levels should be defined based on the facility’s risk appetite and patient sensitivity.
Compliance and Certification
Compliance with ISO 11663-15 can be assessed through:
- Self‑audits: Regular internal audits of water quality records, maintenance logs, and sampling results.
- Third‑party certification: Some facilities seek accreditation under ISO 13485 or national dialysis quality programs that incorporate ISO 11663-15 requirements.
- Regulatory inspection: Health authorities may mandate evidence of compliance during licensing inspections.
It is essential to maintain comprehensive documentation including water quality monitoring plans, standard operating procedures for sampling and testing, training records, and corrective action reports. Retention periods should conform to local regulations but typically span at least three to five years.
Tip: Integrate your dialysis fluid quality records with a digital management system to facilitate trend analysis and early detection of deterioration. Automated alerts on conductivity and pressure parameters can reduce manual oversight.
Frequently Asked Questions
Q: Is ISO 11663-15 identical to the AAMI RD52 standard?
A: ISO 11663:2014 (on which ISO 11663-15 is based) replaced the earlier AAMI RD52:2004. Many national standards, such as CAN/CSA‑ISO 11663-15 in Canada, are direct adoptions of the ISO document. Therefore, compliance with ISO 11663-15 generally satisfies the historical AAMI requirements for dialysis fluid quality.
A: ISO 11663:2014 (on which ISO 11663-15 is based) replaced the earlier AAMI RD52:2004. Many national standards, such as CAN/CSA‑ISO 11663-15 in Canada, are direct adoptions of the ISO document. Therefore, compliance with ISO 11663-15 generally satisfies the historical AAMI requirements for dialysis fluid quality.
Q: What should we do if microbial counts exceed the limit of 100 CFU/mL?
A: Immediately investigate and remediate. Potential causes include biofilm in the distribution loop, exhausted UV lamps, or a malfunctioning RO membrane. Perform corrective disinfection and repeat sampling. Notify the medical director and document all actions. If endotoxin also exceeds 0.25 EU/mL, consider ultrafiltration and more frequent testing until the system stabilises.
A: Immediately investigate and remediate. Potential causes include biofilm in the distribution loop, exhausted UV lamps, or a malfunctioning RO membrane. Perform corrective disinfection and repeat sampling. Notify the medical director and document all actions. If endotoxin also exceeds 0.25 EU/mL, consider ultrafiltration and more frequent testing until the system stabilises.
Q: How often should we test for chemical contaminants?
A: The standard requires at least annual testing for all regulated contaminants. However, if the source water supply undergoes seasonal changes or if new treatment chemicals are introduced, more frequent testing is prudent. Some facilities conduct quarterly testing for key contaminants (e.g., chlorine, aluminium, copper) as an early warning measure.
A: The standard requires at least annual testing for all regulated contaminants. However, if the source water supply undergoes seasonal changes or if new treatment chemicals are introduced, more frequent testing is prudent. Some facilities conduct quarterly testing for key contaminants (e.g., chlorine, aluminium, copper) as an early warning measure.
Q: Is compliance with ISO 11663-15 mandatory?
A: In many jurisdictions, the standard is either mandated by regulation or is considered the accepted state of the art. Even where not strictly mandated, adherence is highly recommended to meet accreditation requirements and to mitigate legal liability in the event of adverse patient events.
A: In many jurisdictions, the standard is either mandated by regulation or is considered the accepted state of the art. Even where not strictly mandated, adherence is highly recommended to meet accreditation requirements and to mitigate legal liability in the event of adverse patient events.